Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
773.00    -11.50 (-1.47%)
Bid:
777.50
Ask:
778.00
Spread: 0.50 (0.064%)
Market Cap: £2.60b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

Share Buyback Programme

2 Jun 2025 14:55

RNS Number : 0744L
Drax Group PLC
02 June 2025
 

2 June 2025

 

DRAX GROUP PLC

(Symbol: DRX)

 

Share Buyback Programme

 

On 28 February 2025, Drax Group plc (the "Company") announced that in connection with the up to £300 million share buyback programme announced on 26 July 2024 to purchase ordinary shares of 11 16/29 pence each in the Company (the "Programme"), it was commencing the third tranche of the Programme up to a maximum consideration of £75 million (the "Third Tranche"). As at 30 May 2025, the Company had repurchased a total of 36,102,728 shares for a consideration of c.£225 million in aggregate across the First, Second and Third Tranches.

 

The Company is today confirming that the fourth tranche of the Programme to purchase ordinary shares in the Company up to a maximum consideration of £75 million (the "Fourth Tranche") will now commence, following the conclusion of the Third Tranche on 30 May 2025.

 

The purpose of the Fourth Tranche is to reduce the Company's share capital. The ordinary shares purchased by the Company will be held in treasury pending cancellation or re-issue.

 

Ordinary share purchases as part of the Fourth Tranche will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volumes. The maximum number of shares that may be repurchased by the Company under the Fourth Tranche of the Programme is 33,469,342 being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the AGM on 1 May 2025 less the shares acquired under the Third Tranche since 1 May 2025.

 

The programme will be carried out through an irrevocable non-discretionary agreement with J.P. Morgan Securities plc ("JPMS plc"), pursuant to which JPMS plc shall purchase ordinary shares as riskless principal (and not as agent of the Company) for the subsequent sale on to, and purchase by, the Company. JPMS plc will make its trading decisions in relation to the ordinary shares independently of, and uninfluenced by, the Company.

 

This arrangement is in accordance with Chapter 9 of the United Kingdom Financial Conduct Authority Listing Rules and the Company's general authority to repurchase shares.

 

The Company will make further announcements in due course following the buyback of shares. Note there is no guarantee that the Programme will be implemented in full.

 

Capitalised terms relate to the Company's announcements on 7 August 2024, 22 October 2024 and 28 February 2025 unless specified otherwise.

 

Enquiries:

Drax Investor Relations: Mark Strafford

+44 (0) 7730 763 949

 

Media:

Drax External Communications: Chris Mostyn

+44 (0) 7743 963 483

 

J.P. Morgan

Robert Constant / Alia Malik

+44 (0) 20 3493 8000

 

Website: www.drax.com

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGGVFZZGKZM
Date   Source Headline
23rd Jun 20202:34 pmRNSHolding(s) in Company
15th Jun 20202:21 pmRNSHolding(s) in Company
12th Jun 202011:54 amRNSHolding(s) in Company
12th Jun 20207:00 amRNS£125 million ESG facility extended to 2025
9th Jun 20203:15 pmRNSDisclosure of rights attached to equity securities
3rd Jun 20204:01 pmRNSHolding(s) in Company
1st Jun 202010:43 amRNSTotal Voting Rights
27th May 20202:30 pmRNSDirector/PDMR Shareholding
15th May 20203:00 pmRNSDirector/PDMR Shareholding
14th May 20209:00 amRNSHolding(s) in Company
11th May 20208:45 amRNSHolding(s) in Company
11th May 20207:00 amRNSDirector/PDMR Shareholding
1st May 20209:00 amRNSTotal Voting Rights
27th Apr 20209:37 amRNSHolding(s) in Company
22nd Apr 202012:45 pmRNSResult of AGM
22nd Apr 20209:00 amRNSHolding(s) in Company
22nd Apr 20207:00 amRNSTrading Update
17th Apr 20209:00 amRNSDirector/PDMR Shareholding
15th Apr 20207:06 amRNSNotice of AGM
9th Apr 20204:28 pmRNSAdditional Listing
8th Apr 20207:00 amRNSDirectorate Change
6th Apr 20204:29 pmRNSRemuneration Policy 2020 – EPS Condition
6th Apr 202011:53 amRNSBlock listing Interim Review - Bonus Matching Plan
6th Apr 202011:51 amRNSBlock listing Interim Review - Sharesave Plan
3rd Apr 20203:35 pmRNSDirector/PDMR Shareholding
1st Apr 20209:00 amRNSDirector/PDMR Shareholding
1st Apr 20208:00 amRNSTotal Voting Rights
30th Mar 20204:12 pmRNSDirector/PDMR Shareholding
27th Mar 20203:18 pmRNSHolding(s) in Company
24th Mar 20203:19 pmRNSHolding(s) in Company
19th Mar 20209:00 amRNSNotice of AGM
10th Mar 20204:26 pmRNSHolding(s) in Company
9th Mar 20207:00 amRNSCapacity Market agreements for existing assets
2nd Mar 20205:15 pmRNSHolding(s) in Company
2nd Mar 202010:51 amRNSTotal Voting Rights
27th Feb 20207:00 amRNSAnnual Financial Report
27th Feb 20207:00 amRNSEnd of Coal Generation at Drax Power Station
19th Feb 20207:00 amRNSNOTICE OF FULL YEAR RESULTS ANNOUNCEMENT
6th Feb 20203:13 pmRNSHolding(s) in Company
4th Feb 20205:05 pmRNSHolding(s) in Company
3rd Feb 202010:19 amRNSTotal Voting Rights
3rd Feb 20207:00 amRNSCapacity Market Agreements
2nd Jan 202011:34 amRNSTotal Voting Rights
16th Dec 201910:02 amRNSNotice of Change to Director Details
10th Dec 20195:53 pmRNSHolding(s) in Company
2nd Dec 201910:01 amRNSTotal Voting Rights
29th Nov 20192:45 pmRNSHolding(s) in Company
19th Nov 20197:00 amRNSCapital Markets Day; Trading Update
13th Nov 20193:34 pmRNSHolding(s) in Company
6th Nov 20191:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.